REM sleep behaviour disorder
Dream enactment parasomnia · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A parasomnia with loss of normal REM atonia causing dream enactment with potentially injurious movements and vocalisations. Strongly predictive of future alpha-synuclein neurodegeneration (Parkinson's disease, dementia with Lewy bodies, MSA), with important counselling implications.
Red flags
- Serious sleep-related injury to patient or bed partner
- Emerging parkinsonism or cognitive decline
- Features suggesting nocturnal seizures instead
- Severe untreated obstructive sleep apnoea
- Falls risk from clonazepam in elderly
Assessment
Differential diagnosis
- Obstructive sleep apnoea with pseudo-RBD
- Non-REM parasomnias (sleepwalking, night terrors)
- Nocturnal seizures
- Periodic limb movement disorder
- Severe nightmares/PTSD
- Medication-induced dream enactment
Investigations
- Video-polysomnography confirming REM sleep without atonia
- Collateral history of dream enactment and injury
- Medication review (SSRIs/SNRIs can induce or unmask RBD)
- Neurological examination for early parkinsonism/cognitive change
- Consider dopaminergic imaging in research/specialist settings
Management
- Take a collateral history of violent dream enactment and sleep-related injury
- Exclude mimics, especially obstructive sleep apnoea and nocturnal seizures
- Confirm with video-polysomnography showing REM without atonia
- Review and rationalise antidepressants that may provoke it
- Prioritise bedroom safety: remove sharp objects, pad surroundings, consider separate beds
- Start melatonin as first-line pharmacotherapy
- Use clonazepam where melatonin is insufficient, with caution in the elderly
- Counsel sensitively about the risk of future neurodegenerative disease
- Monitor longitudinally for emerging parkinsonism or cognitive decline
- Offer support and research/trial opportunities where available
Drugs & doses
Melatonin 3-12 mg PO at bedtime (first-line, prolonged-release or immediate)
Clonazepam 0.25-0.5 mg PO nocte (caution in elderly, falls, cognitive impairment)
Review and reduce SSRIs/SNRIs where feasible
Avoid alcohol and sedatives that fragment sleep
Disposition
Specialist sleep/neurology service. Longitudinal monitoring for neurodegeneration. Safety counselling.
Complications & pitfalls
- Injury to patient or bed partner
- Progression to Parkinson's disease, DLB or MSA
- Clonazepam sedation and falls
- Relationship and sleep disruption
- Psychological distress from prognosis
Exam pearls
- RBD is a strong early marker of alpha-synuclein neurodegeneration; counsel carefully and sensitively
- Bedroom safety is the single most important intervention
- Melatonin is preferred first-line, especially in older or cognitively impaired patients
- Antidepressants can induce or unmask RBD; review them
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.